Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License. ​All of our articles are available to download individually in PDF format.


Editor’s Pick: Emerging Treatment Options in Migraine

Editor’s Pick: Emerging Treatment Options in Migraine

August 10, 2017 at 8:29 AM 0 comments

As we approach an exciting time in migraine therapeutics, my Editor’s Pick for this edition of EMJ Neurology is an article by Karsan et al., detailing the emerging treatment options to reduce the burden of migraine; an under-appreciated, debilitating condition. Recent improvements in our understanding of this condition have ledRead More

The Clinical Development of Cerebrolysin: New Approaches in Stroke Studies. A Commentary to the Cars Study

The Clinical Development of Cerebrolysin: New Approaches in Stroke Studies. A Commentary to the Cars Study

August 10, 2017 at 8:28 AM 0 comments

*Anna Czlonkowska 2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland *Correspondence to czlonkow@ipin.edu.pl Disclosure: Dr Anna Czlonkowska has received honoraria and support with travel grants from Boehringer Ingelheim, Roche, Bayer, EVER Pharma, Nutricia, and Novartis. Received: 15.02.17 Accepted: 15.05.17 Citation: EMJ Neurol. 2017;5[1]:60-64. Abstract Additional efficacious treatmentRead More

Paediatric Primary Headache: Pharmacological and Non-Pharmacological Treatments

Paediatric Primary Headache: Pharmacological and Non-Pharmacological Treatments

August 10, 2017 at 8:27 AM 0 comments

*Jacob Genizi,1,2 Isaac Srugo,2 Nurit Assaf,1 Nogah C. Kerem2,3 1. Pediatric Neurology Unit, Bnai-Zion Medical Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 2. Pediatric Department, Bnai-Zion Medical Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 3. Adolescent Medicine Unit, Bnai-Zion Medical Center, Bruce Rappaport Faculty of Medicine, Technion, Haifa, IsraelRead More

Central Nervous System Disease Associated with Major Viral Haemorrhagic Fever Viruses of Public Health Importance: Challenges in Patient Diagnosis, Evaluation, and Management in Resource-Limited Settings

Central Nervous System Disease Associated with Major Viral Haemorrhagic Fever Viruses of Public Health Importance: Challenges in Patient Diagnosis, Evaluation, and Management in Resource-Limited Settings

August 10, 2017 at 8:26 AM 0 comments

*Peter O. Okokhere,1,2 Mojeed O. Rafiu,1 Idowu A. Bankole1 1. Department of Medicine, Irrua Specialist Teaching Hospital, Irrua, Nigeria 2. Institute of Lassa Fever Research and Control, Irrua Specialist Teaching Hospital, Irrua, Nigeria *Correspondence to okokherep@gmail.com Disclosure: The authors have declared no conflicts of interest. Received: 08.05.17 Accepted: 05.07.17 Citation:Read More

Neurosyphilis: An Important Cause of Recurrent Strokes

Neurosyphilis: An Important Cause of Recurrent Strokes

August 10, 2017 at 8:25 AM 0 comments

*Mohammad Ghaznain, Una Sutton-Fitzpatrick, Mary-Teresa Donnelly Department of Geriatics, General Medicine, Midland Regional Hospital, Tullamore, Offaly, Ireland *Correspondence to ghazitum@hotmail.com Disclosure: The authors have declared no conflicts of interest. Received: 03.01.17 Accepted: 07.07.17 Citation: EMJ Neurol. 2017;5[1]:82-86. Abstract Background: Neurosyphilis can manifest as recurrent brain infarction, although not frequently, butRead More

Focus on the Endogenous Cannabinoid System in Migraine

Focus on the Endogenous Cannabinoid System in Migraine

August 10, 2017 at 8:24 AM 0 comments

*Domenico Chirchiglia, Attilio Della Torre, Pasquale Chirchiglia Department of Neurosurgery, Neurophysiopathology Unit, University of Catanzaro, Catanzaro, Italy *Correspondence to chirchiglia@unicz.it Disclosure: The authors have declared no conflicts of interest. Received: 13.01.17 Accepted: 22.05.17 Citation: EMJ Neurol. 2017;5[1]:88-91. Abstract Migraine prophylaxis represents a better choice than symptomatic drugs, both for safetyRead More

Comprehensive Assessment and Pharmacotherapy of Patients with Chronic Pain Syndrome Due to Diabetic Neuropathy and Postherpetic Neuralgia

Comprehensive Assessment and Pharmacotherapy of Patients with Chronic Pain Syndrome Due to Diabetic Neuropathy and Postherpetic Neuralgia

June 1, 2017 at 8:25 AM 0 comments

*Katarzyna Rygiel Department of Family Practice, Medical University of Silesia, Katowice-Zabrze, Poland *Correspondence to kasiaalpha@yahoo.co.uk Disclosure: The author has declared no conflicts of interest. Received: 25.11.16 Accepted: 24.03.17 Citation: EMJ. 2017;2[2]:35-41. Abstract Management of chronic pain, usually associated with comorbid conditions, remains challenging. General practitioners, together with multidisciplinary teams ofRead More

Paradigm Shift for Thrombolysis for Patients with Acute Ischaemic Stroke, from Extension of the Time Window to the Rapid Recanalisation After Symptom Onset

Paradigm Shift for Thrombolysis for Patients with Acute Ischaemic Stroke, from Extension of the Time Window to the Rapid Recanalisation After Symptom Onset

June 1, 2017 at 8:17 AM 0 comments

Hye Seon Jeong, *Jei Kim Department of Neurology and Daejeon-Chungnam Regional Cerebrovascular Center, Hospital and School of Medicine, Chungnam National University, Daejeon, South Korea *Correspondence to jeikim@cnu.ac.kr Disclosure: The authors have declared no conflicts of interest. Received: 01.02.16 Accepted: 14.06.16 Citation: EMJ. 2017;2[2]:98-103. Abstract Intravenous thrombolysis (IVT) and intra-arterial thrombolysisRead More

State-of-the-Art Advances in Duchenne Muscular Dystrophy

State-of-the-Art Advances in Duchenne Muscular Dystrophy

March 2, 2017 at 8:19 AM 0 comments

Henriette Van Ruiten, Katherine Bushby, *Michela Guglieri The John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle Upon Tyne, UK *Correspondence to michela.guglieri@ncl.ac.uk Disclosure: The authors have declared no conflicts of interest. Received: 24.04.16 Accepted: 17.08.16 Citation: EMJ. 2017;2[1]:90-99. Abstract Duchenne muscular dystrophy (DMD) is a severeRead More

New Developments for Parkinson’s Therapy with COMT Inhibitors

New Developments for Parkinson’s Therapy with COMT Inhibitors

February 2, 2017 at 8:30 AM 0 comments

This symposium took place on 22nd September 2016 as a part of the 89th Deutsche Gesellschaft für Neurologie (DGN) Congress in Mannheim, Germany Chairperson: Heinz Reichmann1 Speakers: Werner Poewe,2 Georg Ebersbach,3 Thomas Müller4 1. Universitätsklinikum Technische Universität Dresden, Dresden, Germany 2. Medizinische Universität Innsbruck, Innsbruck, Austria 3. Neurologisches Fachkrankenhaus für Bewegungsstörungen, Beelitz-Heilstätten,Read More